LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT04666688 · COMPLETED

Trial details

NCT number: NCT04666688
Sponsor: PureTech
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Cancer Solid Tumor Pancreatic Cancer Urothelial Carcinoma Head and Neck Cancer Colorectal Cancer

Start date: 2020-12-15
Primary completion: 2024-12-12
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.